JASMINE BENSON: Open Payments
NPI 1982194874 · OTTUMWA, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 33 payments from 14 companies in 2025. Trend: 2023 $139 · 2024 $253 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 13 | $145 |
| Bioventus LLC | 3 | $65 |
| Abbott Laboratories | 3 | $56 |
| Itamar Medical Inc | 1 | $45 |
| SCPHARMACEUTICALS INC. | 2 | $41 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Baxter Healthcare | 1 | $25 |
| Novo Nordisk Inc | 1 | $20 |
| Boston Scientific Corporation | 1 | $19 |
Products named: CAMZYOS, DUROLANE, CARDIOMEMS, WatchPATONE, FUROSCIX, LifeVest, Kerendia, Hillrom - Cardiac Ambulatory Monitor.
Industry payments across IA — which companies pay providers there.
